Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Accuracy of physical examination, ultrasonography, and magnetic resonance imaging in predicting response to neo-adjuvant chemotherapy for breast cancer.

Chen M, Zhan WW, Han BS, Fei XC, Jin XL, Chai WM, Wang DB, Shen KW, Wang WP.

Chin Med J (Engl). 2012 Jun;125(11):1862-6.

PMID:
22884043
2.
3.

Ultrasound is at least as good as magnetic resonance imaging in predicting tumour size post-neoadjuvant chemotherapy in breast cancer.

Vriens BE, de Vries B, Lobbes MB, van Gastel SM, van den Berkmortel FW, Smilde TJ, van Warmerdam LJ, de Boer M, van Spronsen DJ, Smidt ML, Peer PG, Aarts MJ, Tjan-Heijnen VC; INTENS Study Group.

Eur J Cancer. 2016 Jan;52:67-76. doi: 10.1016/j.ejca.2015.10.010. Epub 2015 Nov 30.

PMID:
26650831
4.

Accuracy of ultrasound for predicting pathologic response during neoadjuvant therapy for breast cancer.

Marinovich ML, Houssami N, Macaskill P, von Minckwitz G, Blohmer JU, Irwig L.

Int J Cancer. 2015 Jun 1;136(11):2730-7. doi: 10.1002/ijc.29323. Epub 2014 Nov 25.

5.

Magnetic resonance imaging and ultrasonography in predicting infiltrating residual disease after preoperative chemotherapy in stage II-III breast cancer.

Guarneri V, Pecchi A, Piacentini F, Barbieri E, Dieci MV, Ficarra G, Tazzioli G, Frassoldati A, Battista R, Canossi B, Mauri C, D'Amico R, Conte P, Torricelli P.

Ann Surg Oncol. 2011 Aug;18(8):2150-7. doi: 10.1245/s10434-011-1590-x. Epub 2011 Feb 8.

PMID:
21301969
6.

Analysis of factors that influence the accuracy of magnetic resonance imaging for predicting response after neoadjuvant chemotherapy in locally advanced breast cancer.

Ko ES, Han BK, Kim RB, Ko EY, Shin JH, Hahn SY, Nam SJ, Lee JE, Lee SK, Im YH, Park YH.

Ann Surg Oncol. 2013 Aug;20(8):2562-8. doi: 10.1245/s10434-013-2925-6. Epub 2013 Mar 6.

PMID:
23463090
7.

Preoperative evaluation of residual tumor extent by three-dimensional magnetic resonance imaging in breast cancer patients treated with neoadjuvant chemotherapy.

Akazawa K, Tamaki Y, Taguchi T, Tanji Y, Miyoshi Y, Kim SJ, Ueda S, Yanagisawa T, Sato Y, Tamura S, Noguchi S.

Breast J. 2006 Mar-Apr;12(2):130-7.

PMID:
16509837
8.

Early prediction of pathologic response to neoadjuvant therapy in breast cancer: systematic review of the accuracy of MRI.

Marinovich ML, Sardanelli F, Ciatto S, Mamounas E, Brennan M, Macaskill P, Irwig L, von Minckwitz G, Houssami N.

Breast. 2012 Oct;21(5):669-77. doi: 10.1016/j.breast.2012.07.006. Epub 2012 Aug 3. Review.

PMID:
22863284
9.

Accuracy of clinical examination, digital mammogram, ultrasound, and MRI in determining postneoadjuvant pathologic tumor response in operable breast cancer patients.

Croshaw R, Shapiro-Wright H, Svensson E, Erb K, Julian T.

Ann Surg Oncol. 2011 Oct;18(11):3160-3. doi: 10.1245/s10434-011-1919-5. Epub 2011 Sep 27.

PMID:
21947594
10.

MRI staging after neoadjuvant chemotherapy for breast cancer: does tumor biology affect accuracy?

McGuire KP, Toro-Burguete J, Dang H, Young J, Soran A, Zuley M, Bhargava R, Bonaventura M, Johnson R, Ahrendt G.

Ann Surg Oncol. 2011 Oct;18(11):3149-54. doi: 10.1245/s10434-011-1912-z. Epub 2011 Sep 27.

PMID:
21947592
11.

Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer.

Yeh E, Slanetz P, Kopans DB, Rafferty E, Georgian-Smith D, Moy L, Halpern E, Moore R, Kuter I, Taghian A.

AJR Am J Roentgenol. 2005 Mar;184(3):868-77.

PMID:
15728611
12.

Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapy.

Schott AF, Roubidoux MA, Helvie MA, Hayes DF, Kleer CG, Newman LA, Pierce LJ, Griffith KA, Murray S, Hunt KA, Paramagul C, Baker LH.

Breast Cancer Res Treat. 2005 Aug;92(3):231-8.

13.

MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy.

Chen JH, Feig B, Agrawal G, Yu H, Carpenter PM, Mehta RS, Nalcioglu O, Su MY.

Cancer. 2008 Jan 1;112(1):17-26. Erratum in: Cancer. 2008 Apr 1;112(7):1642. Feig, Byon [corrected to Feig, Byron].

14.

Accuracy of clinical evaluation of locally advanced breast cancer in patients receiving neoadjuvant chemotherapy.

Prati R, Minami CA, Gornbein JA, Debruhl N, Chung D, Chang HR.

Cancer. 2009 Mar 15;115(6):1194-202. doi: 10.1002/cncr.24154.

15.

Magnetic resonance imaging evaluation of residual tumors in breast cancer after neoadjuvant chemotherapy: surgical implications.

Zhou J, Li G, Sheng F, Qiao P, Zhang H, Xing X.

Acta Radiol. 2016 May;57(5):529-37. doi: 10.1177/0284185115597263. Epub 2015 Jul 31.

PMID:
26231950
16.

MRI in diagnosis of pathological complete response in breast cancer patients after neoadjuvant chemotherapy.

Li YL, Zhang XP, Li J, Cao K, Cui Y, Li XT, Sun YS.

Eur J Radiol. 2015 Feb;84(2):242-9. doi: 10.1016/j.ejrad.2014.11.029. Epub 2014 Dec 3.

PMID:
25533716
17.

Neoadjuvant chemotherapy in breast cancer: prediction of pathologic response with PET/CT and dynamic contrast-enhanced MR imaging--prospective assessment.

Tateishi U, Miyake M, Nagaoka T, Terauchi T, Kubota K, Kinoshita T, Daisaki H, Macapinlac HA.

Radiology. 2012 Apr;263(1):53-63. doi: 10.1148/radiol.12111177.

PMID:
22438441
18.

Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging.

Abraham DC, Jones RC, Jones SE, Cheek JH, Peters GN, Knox SM, Grant MD, Hampe DW, Savino DA, Harms SE.

Cancer. 1996 Jul 1;78(1):91-100.

19.

[Prospective study on the role of MRI and B ultrasonography in evaluating the tumor response to neoadjuvant chemotherapy in breast cancer].

Ye JM, Xu L, Wang DM, Zhao JX, Zhang LB, Duan XN, Liu YH.

Zhonghua Wai Ke Za Zhi. 2009 Mar 1;47(5):349-52. Chinese.

PMID:
19595011

Supplemental Content

Support Center